US Patent 7335468 TSG101-GAG interaction and use thereof

Patent 7335468 was granted and assigned to Myriad Genetics on February, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Myriad Genetics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7335468

Date of Patent

February 26, 2008

Patent Application Number

10663407

Date Filed

September 15, 2003

Patent Citations Received

‌

US Patent 12059413 Methods of inhibiting viruses using compositions targeting TSG101-ubiquitin interaction

Patent Primary Examiner

‌

Jeffrey S. Parkin

Patent abstract

Isolated protein complexes are provided comprising Tsg101 and HIV GAG or GAGp6. The protein complexes are useful in screening assays for selecting compounds effective in modulating the Tsg101-HIV GAG or GAGp6 interaction within the protein complexes.